ArticleParkinson's disease2012

A possible novel anti-inflammatory mechanism for the pharmacological prolyl hydroxylase inhibitor 3,4-dihydroxybenzoate: implications for use as a therapeutic for Parkinson's disease.

Shankar J Chinta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.